Literature DB >> 12757260

Studies on the production of IL-15 in HIV-infected/AIDS patients.

Rasheed Ahmad1, Sardar T A Sindhu, Emil Toma, Richard Morisset, Ali Ahmad.   

Abstract

IL-15 is essential for the development and differentiation of NK cells. It selectively induces proliferation of CD8+ memory T lymphocytes. Despite its importance in both innate and adaptive immune responses, little is known about its production in HIV-infected persons. We report here that IL-15 levels are significantly decreased in the sera of HIV-infected/AIDS patients compared to control sera. We also show that PBMC from the infected patients are compromised in their ability to respond with enhanced production of IL-15 upon exposure to HSV-1. The decreased production of IL-15 occurs despite a comparable increase in IL-15 mRNA in the PBMC of HIV-infected and healthy HIV-seronegative donors when exposed to HSV-1. The HSV-stimulated patients' PBMC exhibited less NK activity compared to similarly treated normal PBMC. These results suggest that a compromised ability of PBMC from HIV-infected individuals to induce IL-15 production in response to a viral stimulus may be a reason of their compromised innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757260     DOI: 10.1023/a:1022568626500

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  57 in total

1.  Binding of the endogenously expressed Epstein-Barr virus (EBV) envelope glycoprotein gp350 with the viral receptor masks the major EBV-neutralizing epitope and affects gp350-specific ADCC.

Authors:  M Khyatti; A Ahmad; M Blagdon; R Frade; J Menezes
Journal:  J Leukoc Biol       Date:  1998-08       Impact factor: 4.962

Review 2.  HIV-induced immunopathogenesis.

Authors:  G M Shearer
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

3.  IL-15 stimulates the expansion of AIDS virus-specific CTL.

Authors:  T Kanai; E K Thomas; Y Yasutomi; N L Letvin
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

Review 4.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels.

Authors:  Y Tagaya; R N Bamford; A P DeFilippis; T A Waldmann
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

Review 5.  Antibody-dependent cellular cytotoxicity in HIV infections.

Authors:  A Ahmad; J Menezes
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

6.  A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  J D Burton; R N Bamford; C Peters; A J Grant; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

Authors:  R N Bamford; A J Grant; J D Burton; C Peters; G Kurys; C K Goldman; J Brennan; E Roessler; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.

Authors:  A Ahmad; R Morisset; R Thomas; J Menezes
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-05

9.  Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15.

Authors:  L Flamand; I Stefanescu; J Menezes
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

10.  Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation.

Authors:  A Blauvelt; H Asada; V Klaus-Kovtun; D J Altman; D R Lucey; S I Katz
Journal:  J Invest Dermatol       Date:  1996-05       Impact factor: 8.551

View more
  10 in total

1.  T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.

Authors:  Annette R Rodriguez; Vida Hodara; Kruthi Murthy; LaShayla Morrow; Melissa Sanchez; Amy E Bienvenu; Krishna K Murthy
Journal:  Cell Immunol       Date:  2014-02-06       Impact factor: 4.868

2.  Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques.

Authors:  Yvonne M Mueller; Constantinos Petrovas; Paul M Bojczuk; Ioannis D Dimitriou; Brigitte Beer; Peter Silvera; Francois Villinger; J Scott Cairns; Edward J Gracely; Mark G Lewis; Peter D Katsikis
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Identification of three immunologic correlates for HIV type 1 pathogenesis in youth.

Authors:  Wei Song; Yufeng Li; Craig M Wilson; Jianming Tang
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-13       Impact factor: 2.205

4.  IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses.

Authors:  Huifeng Yu; Abdul Tawab-Amiri; Amiran Dzutsev; Marianna Sabatino; Karen Aleman; Robert Yarchoan; Masaki Terabe; Yongjun Sui; Jay A Berzofsky
Journal:  J Leukoc Biol       Date:  2011-04-07       Impact factor: 4.962

5.  Differences in Expression of Selected Interleukins in HIV-Infected Subjects Undergoing Antiretroviral Therapy.

Authors:  Beata Szymańska; Karolina Jurkowska; Brygida Knysz; Agnieszka Piwowar
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

6.  Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.

Authors:  G d'Ettorre; G Forcina; M Andreotti; L Sarmati; L Palmisano; M Andreoni; S Vella; C M Mastroianni; V Vullo
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

7.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

8.  Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation.

Authors:  Sanjay Swaminathan; Ju Qiu; Adam W Rupert; Zonghui Hu; Jeanette Higgins; Robin L Dewar; Randy Stevens; Catherine A Rehm; Julia A Metcalf; Brad T Sherman; Michael W Baseler; H Clifford Lane; Tomozumi Imamichi
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

9.  Altered Cervical Mucosal Gene Expression and Lower Interleukin 15 Levels in Women With Schistosoma haematobium Infection but Not in Women With Schistosoma mansoni Infection.

Authors:  Kathryn M Dupnik; Myung Hee Lee; Pallavi Mishra; Mary Juliet Reust; Soledad Colombe; Syeda Razia Haider; Benjamin Yao; Kaitlin Vick; Tuo Zhang; Jenny Xiang; Donald Miyaye; Ruth Magawa; Eric Lyimo; Crispin Mukerebe; Julius Mngara; Samuel E Kalluvya; Claudia J de Dood; Govert J van Dam; Paul L A M Corstjens; Jennifer A Downs
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

Review 10.  Apoptosis of uninfected cells induced by HIV envelope glycoproteins.

Authors:  Barbara Ahr; Véronique Robert-Hebmann; Christian Devaux; Martine Biard-Piechaczyk
Journal:  Retrovirology       Date:  2004-06-23       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.